Page 19 - Pharma Stocks

Brokerages are betting on pharma stocks with India focus: Analysts

While domestic growth is pegged at double digits, recovery in the US may take a couple of quarters

Pharma stocks rally on buzz about new Covid variant, travel stocks sink

Huge gains for Cipla, Alkem Labs and Dr Lal Path, even as IndiGo, Chalet Hotels and IHC tank

Market wrap: Sensex sinks 1,688 pts, Nifty holds 17K; Rs 7.5-trn investor wealth lost

Pharma stocks soar as investors turn to defensive bets; dollar index inches towards 97 mark

BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%

The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.

GSK Pharma surges 11%, hits 52-week high on improved outlook

The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.

Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals

On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals

Strides Pharma hits 52-week low, slumps 9% on weak Q2 results

The management said a muted sales performance accompanied with a drop in gross margins and relatively higher operating costs has led to a negative operating leverage in H1

Pharma funds lag sectoral peers despite Covid tailwind as US market weighs

In the year to date, the Nifty pharma index has returned 8.8 per cent, with 10 of its constituents giving negative returns

Pharma shares under pressure; Aurobindo, Wockhardt, Hikal, Natco down 6%

Natco Pharma said that a US District Court has issued a decision in favour of Pharmacyclics (a subsidiary of AbbVie), the brand owner of Imbruvica in a PIV litigation involving the product..

Aurobindo Pharma hits 52-week low, slips 25% in one month

The stock of the pharmaceutical company was trading at its lowest level since June 2020

Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex

Natco Pharma slips 6% as Delhi HC allows injunction application by FMC Corp

The Hon'ble High Court of Delhi today orally pronounced judgment in the interim injunction application filed by FMC Corporation on CTPR

Markets log first gain in 5 days; financial, pharma stocks take charge

After a range-bound trading through the day, the BSE Sensex ended 166.07 points or 0.32 per cent higher at 52,484.67

Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks

After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100

Indian shares open flat as pharma boost offsets losses in tech stocks

Indian shares were largely unchanged on Monday, as gains in pharmaceutical stocks and heavyweight Reliance Industries were offset by losses in information technology stocks

Sensex rebounds 359 points; financial, pharma stocks key drivers

The 30-share Sensex finished 358.83 points or 0.69 per cent higher at 52,300.47. Intra-day, the index swung between a high of 52,346.35 and a low of 51,957.92

After 100% gain since Nov, can the rally in Gland Pharma stock continue?

Gland's prospects remain strong, say analysts, as it has a robust pipeline of products with 50 pending Abbreviated New Drug Applications (ANDAs) and a healthy filing rate of 21 ANDAs in 9MFY21

Cipla dips 4% on lower than expected March quarter earnings

The company's performance in Q4FY21 was weighed by moderate YoY growth in India Domestic Formulation (DF)/South Africa and decline in API sales for the quarter

Sensex, Nifty rise for 4th straight session; pharma, banking stocks gain

Over the last four sessions, the Sensex has gained 1,248.90 points or 2.58 per cent.

Laurus Labs shares advance 5% on strong growth outlook

Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model